Celemics

Celemics develops tools and reagents that help scientists read, copy, and work with DNA, the genetic blueprint underlying drug discovery, disease diagnosis, and biological research.

Its products serve researchers and laboratories across modern medicine and molecular biology. The company focuses on integrating previously separate steps in the DNA-handling workflow, separation, sequencing, cloning, and synthesis, into a unified, high-throughput platform that reduces manual work and cost. It is listed on KOSDAQ, South Korea's technology and small-cap stock exchange.